Unlike the SLC30A10 gene, which is methylated in colorectal cancer in the majority of cases [23,24], according to the COSMIC knowledge base [“https://cancer.sanger.ac.uk/cosmic (accessed on 31 May 2024)”], it can be explained by methylation in only ~7% of cases, which likely implies that other, non-methylation-related mechanisms of suppression are also involved. This evidence concerns the gene SLC30A10 and colorectal cancer.